Easy way to accelerate the scale-up of innovative soft devices for Drug Discover...
Easy way to accelerate the scale-up of innovative soft devices for Drug Discovery pipeline
Cell&Soft is a Deeptech company based in France (AURA region) which aims to develop, produce and sale innovative solutions for in vitro cell culture, in the field of oncology and stem cell research.
Pain point: Drug development p...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Información proyecto Easy SOFT
Duración del proyecto: 12 meses
Fecha Inicio: 2022-06-02
Fecha Fin: 2023-06-30
Líder del proyecto
CELL AND SOFT
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
75K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Cell&Soft is a Deeptech company based in France (AURA region) which aims to develop, produce and sale innovative solutions for in vitro cell culture, in the field of oncology and stem cell research.
Pain point: Drug development process is very expensive, complex and suffers from many failures. In oncology, the average success rate is less than 4%. More than 80% of drug candidates fail in early clinical phases and this after 5 to 7 years of research. Thus, the efforts mobilized consume considerable human and financial resources, without result.
Opportunities: One of the most important challenges is the lack of reliable, reproducible, and easy-to-use in vitro models, allowing better predictability and/or reliable diagnosis.
Ambition: At Cell&Soft, our ambition is to re-invent in vitro cell culture, by developing innovative devices that act as steppingstones for tomorrow's drug candidates. The objective of Cell&Soft is to accelerate the discovery of new drugs with an average success rate of more than 20%, while limiting the use of animal models.
Easy SOFT project: The Women TechEU program is a great opportunity to achieve our ambition by accelerating the growth of Cell&Soft. The Easy SOFT project must allow us to (1) consolidate our added value by strengthening our POCs and IP financing, (2) prepare strategic and operational commercial deployments, and (3) allow a scale up to a pre-industrial stage to meet the Pharma companies at the international level.
Women empowerment: As a women scientist and CEO, I want to promote the integration of women in science and in leadership roles. I think I can challenge the status quo to create an environment where women can achieve their potential. Through the Women Leadership Program I want to deploy myself as a female mentor and gain access to new networks within the European innovation ecosystem.